Design terms
|
#1
|
"randomized controlled trial (topic)"/exp
|
37,931
|
|
#2
|
"randomized controlled trial"/exp
|
337,523
|
|
#3
|
"randomization"/exp
|
61,698
|
|
#4
|
"double blind procedure"/exp
|
115,032
|
|
#5
|
[controlled clinical trial]/lim
|
511,199
|
|
#6
|
[randomized controlled trial]/lim
|
337,523
|
|
#7
|
"clinical trial"/exp
|
961,450
|
|
#8
|
"clinical trial (topic)"/exp
|
73,222
|
|
#9
|
#1 OR #2 OR #3 OR #4 OR #5 OR #6
|
1,088,520
|
|
#10
|
singl*: ab,ti OR doubl*: ab,ti OR treb*: ab,ti OR tripl*: ab,ti AND (blind*: ab,ti OR mask*: ab,ti)
|
174,394
|
|
#11
|
"placebo"/exp
|
236,244
|
|
#12
|
random* AND (clinical OR control*) AND trial OR (placebo* AND ("randomly allocated" OR (allocated AND random*)))
|
504,649
|
|
#13
|
(#7 OR #8) AND (#10 OR #11 OR #12)
|
513,722
|
|
#14
|
#9 OR #13
|
705,098
|
Exclusion terms
|
#15
|
[conference review]/lim
|
3,863
|
|
#16
|
"case report":ab,ti
|
256,868
|
|
#17
|
[review]/lim
|
2,026,389
|
|
#18
|
[letter]/lim
|
827,115
|
|
#19
|
"phase 1 clinical trial"/exp
|
24,619
|
|
#20
|
[short survey]/lim OR "historical article": ab,ti
|
514,714
|
|
#21
|
"systematic review": ab,ti
|
78,920
|
|
#22
|
"clinical review": ab,ti
|
3,904
|
|
#23
|
#15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22
|
3,628,070
|
|
#24
|
#14 NOT #23
|
424,301
|
Rx terms
|
#25
|
"drug therapy"/exp/mj
|
574,153
|
|
#26
|
"treatment response"/exp/mj
|
2,763
|
|
#27
|
"treatment outcome"/exp/mj
|
28,936
|
|
#28
|
"drug efficacy"/exp/mj
|
153,753
|
|
#29
|
"outcome assessment"/exp/mj
|
9,603
|
|
#30
|
chemothera* OR ("drug"/exp/mj AND thera*) OR antineoplastic* OR palliat* OR standar* NEAR/2 care OR support* NEAR/2 care OR "best supportive care" OR best?support* NEXT/2 care
|
1,895,030
|
|
#31
|
"radiotherapy"/exp
|
367,367
|
|
#32
|
#25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31
|
2,609,134
|
|
#33
|
#23 AND #31
|
88,937
|
Disease terms
|
#34
|
((lung$ OR pulmon$) NEAR/5 (adenocarcinom$ OR squamous OR "large cell" OR "non-small cell")): ab,ti
|
44,817
|
|
#35
|
"lung non small cell cancer"/exp
|
52,027
|
|
#36
|
metastatic: ab,ti
|
181,820
|
|
#37
|
advanced: ab,ti
|
320,393
|
|
#38
|
stage 3: ab,ti
|
61
|
|
#39
|
"Stage 3": ab,ti
|
8,708
|
|
#40
|
stage 4: ab,ti
|
32
|
|
#41
|
"stage 4": ab,ti
|
5,270
|
|
#42
|
stage iii: ab,ti
|
30
|
|
#43
|
"stage iii": ab,ti
|
31,468
|
|
#44
|
stage iv: ab,ti
|
41
|
|
#45
|
"stage iv": ab,ti
|
20,205
|
|
#46
|
"stage iii/iv": ab,ti
|
6
|
|
#47
|
"stage iii/iv": ab,ti
|
4,552
|
|
#48
|
"stage iiib/iv": ab,ti
|
2
|
|
#49
|
"stage iii/iva": ab,ti
|
1
|
|
#50
|
stage* iii: ab,ti
|
32
|
|
#51
|
stage* iii*: ab,ti
|
49
|
|
#52
|
stage* iv: ab,ti
|
41
|
|
#53
|
stage* iv*: ab,ti
|
52
|
|
#54
|
stage iii*: ab,ti
|
47
|
|
#55
|
stage iv*: ab,ti
|
46
|
|
#56
|
inoperable: ab,ti
|
12,989
|
|
#57
|
in* operable: ab,ti
|
13,465
|
|
#58
|
unresectable: ab,ti
|
15,735
|
|
#59
|
non* resectable: ab,ti
|
1,208
|
|
#60
|
late* stage: ab,ti
|
84
|
|
#61
|
late: ab,ti AND stage: ab,ti
|
41,346
|
|
#62
|
metast*: ab,ti OR advance*: ab,ti
|
900,959
|
|
#63
|
relaps* OR recurr* OR unresect* OR non?resect* OR in?operable OR non?operable OR un?operable OR advanc* OR metasta* OR late NEAR/2 stage
|
1,895,338
|
|
#64
|
#34 OR #35
|
61,621
|
|
#65
|
#36 OR #37 OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR #49 OR #50 OR #51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 OR #60 OR #61 OR #62 OR #63
|
1,943,775
|
|
#66
|
#64 AND #65
|
33,907
|
|
#67
|
#33 AND #66
|
2,689
|
Language and year
|
#68
|
[1995–2013]/py AND [english]/lim
|
12,998,680
|
Final
|
#69
|
#67 AND #68
|
2,901
|